Dr Reddy’s Q4 FY25 net up 21% at ₹1,587 crore

Pharma major Dr Reddy’s Laboratories Ltd’s consolidated net profit increased 21 per cent in the fourth quarter ended March 31, 2025 at ₹1,587 crore against ₹1,307 crore in the corresponding period of previous financial year. 

The total revenue of the Hyderabad-based company increased 20 per cent at ₹8,506 crore in the period under review compared to ₹7,083 crore in the year-ago period. 

Commenting on the results, co-chairman & MD, GV Prasad, said: “We achieved double-digit growth across our businesses, driven by successful product launches, increased revenues from key products in the US and the integration of the acquired NRT business.’‘

Dr Reddy’s will continue to strengthen and grow its core businesses through portfolio management and operational excellence, while pursuing strategic partnerships and inorganic growth opportunities, he added. 

For the full year FY25, it posted a 2 per cent increase in net profit at ₹5,655 crore on a 17 per cent growth in revenue at ₹3,255.4 crore.

Published on May 9, 2025